Biotech ApS WG
CIK 1753193 · last filed 2025-09-18
Biotech ApS WG is a corporate insider who has filed 12 SEC Form 4 insider transactions across 1 company since 2019. Across all open-market trades the lifetime net is −$7.8M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
12
-$7.83M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Director | 4,559,233 | $8.61 | $39.25M | -$7.83M | 11 | 2023-12-12 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-18 | — | U | −4,559,233 | -$39.21M | |
| 2023-12-12 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +6,455 | $44.2K | EDGAR |
| 2023-12-11 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +127,549 | $890.4K | EDGAR |
| 2023-12-01 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +51,837 | $309.5K | EDGAR |
| 2023-11-29 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +93,187 | $521.3K | EDGAR |
| 2023-05-17 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Buy (P) | +101,740 | $981.4K | EDGAR |
| 2021-06-11 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Sell (S) | −11,229 | -$406.0K | EDGAR |
| 2021-06-10 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Sell (S) | −150,000 | -$5.40M | EDGAR |
| 2021-06-09 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Sell (S) | −72,400 | -$2.47M | EDGAR |
| 2021-06-07 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Sell (S) | −34,507 | -$1.15M | EDGAR |